WebDec 12, 2024 · ATLANTA, Ga., December 12, 2024 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today longer-term results from the Phase 1b/2 CARTITUDE-1 study evaluating the efficacy and safety of ciltacabtagene autoleucel (cilta-cel), an investigational B-cell maturation antigen (BCMA)-directed chimeric antigen … WebDec 5, 2024 · December 5, 2024 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today longer-term results from the combined Phase 1b/2 CARTITUDE-1 study (NCT03548207) evaluating the efficacy and safety of ciltacabtagene autoleucel (cilta-cel), an investigational B cell maturation antigen (BCMA) …
A Long-term Study for Participants Previously Treated With ...
WebMar 1, 2024 · Federal regulators have approved a new CAR T cancer drug as a treatment for certain forms of multiple myeloma. Cancer experts say the approval of cilta-cel will provide more options for people who ... WebMar 1, 2024 · The FDA has granted approval of ciltacabtagene autoleucel (cilta-cel; Carvykti) for the treatment of adults with relapsed or refractory multiple myeloma who … how to remove pimple on eyelid
Updated Data on Cilta-Cel at ASCO 2024 Int Myeloma Fn
WebMay 26, 2024 · U.S. Food and Drug Administration Grants BCMA CAR-T Cilta-cel Priority Review for the Treatment for Relapsed/Refractory Multiple Myeloma. May 26, 2024 … WebMar 1, 2024 · On February 28, the Food and Drug Administration (FDA) approved Carvykti (ciltacabtagene autoleucel, or cilta-cel), a new CAR-T therapy for the treatment of adults … WebSep 15, 2024 · The primary objectives are characterization of cilta-cel safety, including cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome, and confirmation of the ... how to remove pimple ma